Overview

Everolimus in Restoring Salivary Gland Function in Participants With Locally Advanced Head and Neck Cancer Treated With Radiation Therapy

Status:
Terminated

Trial end date:
2019-11-15

Target enrollment:

Participant gender:

Summary

This early phase 1 trial studies the use of everolimus in restoring salivary gland function in participants with locally advanced head and neck cancer after concurrent chemoradiation or radiation therapy alone.

Phase:

Early Phase 1

Details

Lead Sponsor:

University of Arizona

Collaborator:

National Cancer Institute (NCI)

Treatments:

Everolimus
Sirolimus